Jalolov Returns Against Dacres On Dubois-Wardley 2Jalolov Returns Against Dacres On Dubois-Wardley 2
Bakhodir Jalolov portrait
Photo: National Olympic Committee of the Republic of Uzbekistan / Wikimedia Commons (CC BY 4.0)
Advertisement
BOXINGBoxing News

Jalolov Returns Against Dacres On Dubois-Wardley 2

Aaron Clarke
Lightweight & Featherweight Writer ·

This author receives a commission through recommended links in this content. See our affiliate disclosure.

Two-time Olympic gold medalist Bakhodir Jalolov will face Solomon Dacres in the co-main event when Daniel Dubois and Fabio Wardley run it back on October 17th, according to Dan Rafael.

Jalolov remains undefeated at 17-0 with 15 knockouts but has yet to face serious professional opposition despite turning pro in 2018. The Uzbek heavyweight reached the quarterfinals at Rio 2016, where he lost to Joe Joyce, then claimed gold at both Tokyo 2020 and Paris 2024. After that second Olympic triumph, he announced his retirement from amateur boxing to focus on the paid ranks, though his level of competition has not reflected that shift.

🎟️ Get tickets: Buy tickets to Dubois vs Wardley 2 on Ticketmaster →

Jalolov's Recent Pro Form Raises Questions

Going to the fight?
Dubois vs Wardley 2
O2 Arena · London · 17 Oct 2026
Get Tickets

Two of his last three outings have gone the distance, and his most recent stoppage came against Agron Smakichi on the first Dubois-Wardley card in a performance Bad Left Hook described as one that "stank out the joint." Dacres likely represents a step up from that level. The Brit is 10-1 with three knockouts and bounced back from an 80-second demolition by David Adeleye in 2024 to shut out previously unbeaten Vladyslav Sirenko last year.

Dacres was scheduled to meet Jared Anderson earlier this year before Anderson withdrew on late notice. The October 17th card takes place in London with the heavyweight rematch between Dubois and Wardley topping the bill.


Reported via:

Advertisement
Advertisement

Get Ringside Updates

Fight announcements, results, and analysis delivered to your inbox. No spam. Unsubscribe anytime.

Send me:

Join the discussion

Loading the discussion…